The future of the global medical polymer market in 2016-2025 is clearly optimistic
The future of the global medical polymer market in 2016-2025 is clearly optimistic
In April 2017, it was announced that the implant would account for $1.7 billion in polymer sales by 2021, according to the us-based industry analytics company n-tech Research. The company has released a report called "2016-2025 global medical polymer market", confirming the industry's technology, trends and regulatory framework. That is a new global medical polymer market report to global growth in 2025 is analyzed, also delves into the polymer supplier how to create new business income in the field of medical application.
Global medical polymer market (2016-2025) : published by n-tech research and can be purchased on the site. The report provides guidance and regulatory matters relating to the technology, as well as the archives of major companies in the medical market. According to the report, the implants, which account for more than half of the medical polymer, will have sales of nearly $1.7 billion by 2021. Diagnosis system will achieve more than $1 billion in sales over the same period, the plastic in the high-speed development of multi-function devices have become an integral part of the industry's growth prospects is very strong.
Among them: $2.9 billion in global medical polymer revenue by 2021. The study also shows that polymer will be used widely in the implant market, because it is cheaper and less quantifiable, and can effectively replace metal, such as titanium. Similar trends will also drive the market for diagnostics, which is expected to reach $1 billion by 2021. Among them, the polymer PMMA will make the largest contribution, will account for the largest proportion of medical income, and will reach $745 million in sales by 2021. PS, styrene, LDPE and PEEK are also thought to be the most valuable medical polymer, with the four types of polymers that will account for 54% of the medical polymer market by 2021. In the report also lists the global leading supplier of medical polymer and analyzes the advantages and disadvantages as well as the development strategy, by listed companies, including: dow chemical, du pont, Eastman chemical, evonik, Nicholas, etc. The report also includes chapters on investment opportunities in the emerging markets and forecasts for the next eight years in China, Japan and India.
In addition, the start-up Restoration Medical products (RMP) announced on the eve of 2016 that it would invest more than $7 million to build a 36,000 square foot facility in whitley county, Kentucky. The new plant will focus on developing and producing medical grade polymers for portable applications and moving the company's headquarters and high-tech testing laboratories into it. The plant will be completed by the end of 2016 and will begin production in early 2017. According to the company, as many as 20 full-time positions will be created by 2019, most of them highly skilled technicians and engineers. RMP is currently located at the enterprise incubation center supported by Micropulse Inc., which provides the production and packaging services for the plastic surgery department. RMP is led by Lou Matrisciano, President and chief executive officer, who was the global head of technology for global plastics inc. 's U.S. Quadrant EPP. According to the indiana economic development board, according to a press release RMP program in 2016, cooperation with customers, research and development of those in the rapid development of polymer in the market is in their immediate needs of material and process. The expectation of RMP is to develop processing technologies that can transition to the next generation of polymer products and for the interest of medical device manufacturers and suppliers.
